Socialguy, what I would like to know is what happened in the US around 10.45 am yesterday?
Someone in the know over there I believe?
Novogen Limited (NVGN)
-NasdaqCM
2.790.25(9.84%) 06:00
Add to Portfolio
Prev Close: 2.54 1 Open: 2.55 2 Bid: 2.82 x 100 3 Ask: 3.75 x 2000 4 1y Target Est: 3.51 5 Beta: -1.0746 6 Next Earnings Date: N/A
Day's Range: 2.51 - 2.79 1 52wk Range: 1.51 - 9.50 2 Volume: 127,259 3 Avg Vol (3m): 179,006 4 Market Cap: 47.22M 5 P/E (ttm): N/A 6 EPS (ttm): -0.53 7 Div & Yield: N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
» More Headlines for NVGN
- Novogen (NVGN) Conducts Scientific Review of R&D ProgramZacks(Tue 1 Sep)
- Novogen Announces The Outcome Of A Comprehensive Science ReviewPR Newswire(Mon 31 Aug)
- Newly Appointed Acting CEO Outlines Immediate Plans for NovogenPR Newswire(Thu 30 Jul)
- Novogen Appoints Iain Ross as Acting CEO and Re-appoints Him to the BoardPR Newswire(Wed 22 Jul)
- Anisina Receives Orphan Drug Designation from FDA for NeuroblastomaPR Newswire(Thu 16 Jul)
- Pre-clinical Studies Suggest Anisina May Improve Chemotherapy Effectiveness in Childhood CancerPR Newswire(Tue 14 Jul)
- H.C. Wainwright: Time To Buy NovogenBenzinga(Wed 1 Jul)
- Coverage initiated on Novogen by H.C. WainwrightBriefing.com(Wed 1 Jul)
- Novogen Announces the Chairman's Address at the Company's General MeetingPR Newswire(Wed 24 Jun)
- Anisina on Track to Enter Clinic in 2016PR Newswire(Wed 24 Jun)
Press Releases
» More Press Releases for NVGN
- Novogen Announces The Outcome Of A Comprehensive Science ReviewPR Newswire(Mon 31 Aug)
- Newly Appointed Acting CEO Outlines Immediate Plans for NovogenPR Newswire(Thu 30 Jul)
- Novogen Appoints Iain Ross as Acting CEO and Re-appoints Him to the BoardPR Newswire(Wed 22 Jul)
Prev Close: 2.54 1 Open: 2.55 2 Bid: 2.82 x 100 3 Ask: 3.75 x 2000 4 1y Target Est: 3.51 5 Beta: -1.0746 6 Next Earnings Date: N/A
Day's Range: 2.51 - 2.79 1 52wk Range: 1.51 - 9.50 2 Volume: 127,259 3 Avg Vol (3m): 179,006 4 Market Cap: 47.22M 5 P/E (ttm): N/A 6 EPS (ttm): -0.53 7 Div & Yield: N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Novogen (NVGN) Conducts Scientific Review of R&D ProgramZacks(Tue 1 Sep)
- Novogen Announces The Outcome Of A Comprehensive Science ReviewPR Newswire(Mon 31 Aug)
- Newly Appointed Acting CEO Outlines Immediate Plans for NovogenPR Newswire(Thu 30 Jul)
- Novogen Appoints Iain Ross as Acting CEO and Re-appoints Him to the BoardPR Newswire(Wed 22 Jul)
- Anisina Receives Orphan Drug Designation from FDA for NeuroblastomaPR Newswire(Thu 16 Jul)
- Pre-clinical Studies Suggest Anisina May Improve Chemotherapy Effectiveness in Childhood CancerPR Newswire(Tue 14 Jul)
- H.C. Wainwright: Time To Buy NovogenBenzinga(Wed 1 Jul)
- Coverage initiated on Novogen by H.C. WainwrightBriefing.com(Wed 1 Jul)
- Novogen Announces the Chairman's Address at the Company's General MeetingPR Newswire(Wed 24 Jun)
- Anisina on Track to Enter Clinic in 2016PR Newswire(Wed 24 Jun)
- Novogen Announces The Outcome Of A Comprehensive Science ReviewPR Newswire(Mon 31 Aug)
- Newly Appointed Acting CEO Outlines Immediate Plans for NovogenPR Newswire(Thu 30 Jul)
- Novogen Appoints Iain Ross as Acting CEO and Re-appoints Him to the BoardPR Newswire(Wed 22 Jul)
» More Press Releases for NVGN
Check out the large Spike in Volume around 10.45AM in the US Yesterday.
Column 1 1
There has to be some news coming IMHO>
- Forums
- ASX - By Stock
- KZA
- Major breakout of NVGN on NASDAQ
Major breakout of NVGN on NASDAQ, page-4
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)